Ethyl 3,4-dihydroxybenzoate is a HIF-1alpha agonist. Ethyl 3,4-dihydroxybenzoate stabilizes HIF-1alpha by inhibiting PHD, activates downstream pathways to induce autophagy and apoptosis of tumor cells, and regulates inflammatory responses, inhibits the NF-kappaB pathway, improves vascular permeability, and promotes osteoblast differentiation.
Molecular Weight:
182.18
Purity:
>99.0%
CAS Number:
[3943-89-3]
Formula:
C9H10O4
Target:
HIF
* VAT and and shipping costs not included. Errors and price changes excepted
